| BGLC Shares Outstanding History Table | ||||||||||||||||||||||||
Below is a table of the BGLC shares outstanding history going back to 7/20/2023:
Also see: BGLC Market Cap History BGLC YTD Return |
BGLC Shares Outstanding History — BioNexus Gene Lab Share Count Over Time
As of 12/31/2025 BioNexus Gene Lab has 2.42 million BGLC shares outstanding. Investors often track the BGLC shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows BGLC share count trends over time, with 11 historical shares outstanding datapoints presented, dating back to 7/20/2023.
| BGLC Shares Outstanding History Chart | |||||||||||||||||||||||||
BGLC Historical Shares Outstanding: +19.15% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||
| BGLC Stock Price Chart |
| About BioNexus Gene Lab Corp |
| BioNexus Gene Lab is a molecular diagnostics company focused on the application of functional genomics. Co.'s focus is on developing and marketing non-invasive blood tests for early detection of diseases. Co.'s non-invasive blood tests analyze changes in ribonucleic acid to detect the risk potentiality of various diseases. These diseases include cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate and colon), bowel diseases (colitis and Crohn) and osteoarthritis. This blood based genomic biomarker approach is based on the scientific observation that circulating blood reflects, in a detectable way, what is occurring throughout the body. We show 11 historical shares outstanding datapoints in our coverage of BGLC's shares outstanding history. Understanding the changing numbers of BGLC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BGLC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BGLC by allowing them to research BGLC shares outstanding history as well as any other stock in our coverage universe. |
| BGLC Current Stock Quote |
Quotes delayed 20 minutes  Free BGLC Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| BGLC Share Performance |
| Shares Outstanding Peers |
| BioNexus Gene Lab (BGLC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
BGMS Shares Outstanding History BGXX Shares Outstanding History BHG Shares Outstanding History BIAF Shares Outstanding History BIIB Shares Outstanding History BIMI Shares Outstanding History BIO Shares Outstanding History BIOC Shares Outstanding History BIOL Shares Outstanding History BIOR Shares Outstanding History More Healthcare companies » |
BGLC Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
